Product NDC: | 50419-828 |
Proprietary Name: | DESONATE |
Non Proprietary Name: | desonide |
Active Ingredient(s): | .5 mg/g & nbsp; desonide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-828 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021844 |
Marketing Category: | NDA |
Start Marketing Date: | 20061020 |
Package NDC: | 50419-828-12 |
Package Description: | 2 TUBE in 1 CARTON (50419-828-12) > 60 g in 1 TUBE |
NDC Code | 50419-828-12 |
Proprietary Name | DESONATE |
Package Description | 2 TUBE in 1 CARTON (50419-828-12) > 60 g in 1 TUBE |
Product NDC | 50419-828 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | desonide |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20061020 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | DESONIDE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |